Trials / Completed
CompletedNCT04468815
A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)
An Open-Label Study to Assess Relative Bioavailability, Food Effect, and Esomeprazole Drug-Drug Interaction of BMS-986278 Tablets Following a Single Dose Administration in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess levels in blood plasma of BMS-986278 and the food effect in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986278 Tablet | Specified dose on specified days |
| DRUG | Esomeprazole | Specified dose on specified days |
| DRUG | BMS-986278 suspension | Specified dose on specified days |
Timeline
- Start date
- 2020-07-10
- Primary completion
- 2020-10-07
- Completion
- 2020-10-07
- First posted
- 2020-07-13
- Last updated
- 2022-05-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04468815. Inclusion in this directory is not an endorsement.